HLA testing in patients with uveitis

International Ophthalmology Clinics

Volumn 40, Issue 2, 2000, Pages 19-35

  Yabuki, Kazuro ^a   Inoko, Hidetoshi ^a   Ohno, Shigeaki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; HLA B ANTIGEN; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

BEHCET DISEASE; CHORIORETINOPATHY; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HLA SYSTEM; HUMAN; INTERMEDIATE UVEITIS; JUVENILE RHEUMATOID ARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK; SARCOIDOSIS; SYMPATHETIC OPHTHALMIA; UVEITIS; VOGT KOYANAGI SYNDROME;

EID: 0034092854     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200004000-00004     Document Type: Review

References (86)

1. Behçet's Disease Research Committee of Japan. Behçet's disease: guide to diagnosis of Behçet's disease. Jpn J Ophthalmol 1974;18:291-294
2. International study group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-1080
3. Yazici H, Chamberlain MA, Schreuder I, et al. HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients. Ann Rheum Dis 1980;39:344-348
4. Mizuki N, Inoko H, Tanaka H, et al. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51. Invest Ophthalmol Vis Sci 1992;33:3332-3340
5. Chung YM, Liu JH, Tsi ST. Behçet's disease in Taiwan - a review of 53 cases. Jpn J Ophthalmol 1986;30:318-323
6. Baricordi OR, Sensi A, Pivetti-Pezzi P, et al. Behçet's disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol 1986;17:297-301
7. Al-Rawi ZS, Sharquie KE, Khalifa SJ, et al. Behçet's disease in Iraqi patients. Ann Rheum Dis 1986;45:987-990
8. Arber N, Klein T, Meiner Z, et al. Close association with HLA-B51 and B52 in Israeli patients with Behçet's syndrome. Ann Rheum Dis 1991;50:351-353
9. Kilmartin DJ, Finch A, Acheson RW. Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 1997;81:649-653
10. Yabuki K, Mizuki N, Ota M, et al. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci 1999;40:1921-1926
11. Mizuki N, Inoko H, Ando H, et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B*5101. Am J Ophthalmol 1993;116:406-409
12. Mizuki N, Ohno S, Ando H, et al. A strong association between HLA-B*5101 and Behçet's disease in Greek patients. Tissue Antigens 1997;50:57-60
13. Gonzalez-Escribano MF, Rodriguez MR, Walter K, et al. Association of HLA-B51 subtypes and Behçet's disease in Spain. Tissue Antigens 1998;52:78-80
14. Mizushima Y, Matsuda T, Hoshi K, Ohno S. Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test. J Rheumatol 1988;15:1029-1030
15. Pervin K, Childerstone A, Schinnick T, et al. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol 1993;151:2273-2282
16. Sakamoto M, Akazawa K, Nishioka Y, et al. Prognostic factors of vision in patients with Behçet's disease. Ophthalmology 1995;102:317-321
17. Mizuki N, Ohno S, Sato T, et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. Hum Immunol 1995;43:129-135
18. Mizuki N, Ohno S, Ando H, et al. HLA-C genotyping of patient with Behçet's disease in the Japanese population. Hum Immunol 1996;50:47-53
19. Mizuki N, Ota M, Kimura M, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proc Natl Acad Sci U S A 1997;94:1298-1303
20. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994;91:6259-6263
21. Groh V, Bahram S, Bauer S, et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996;93:12445-12450
22. Zwirner NW, Fernandez-Vina MA, Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 1998;47:139-148
23. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gamma delta T cells. Science 1998;279:1737-1740
24. Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J Rheumatol 1994;21:2301-2306
25. Hasan A, Fortune F, Wilson A, et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet 1996;347:789-794
26. Ohno S. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases. Trans Ophthalmol Soc U K 1981;101:335-341
27. Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1992;113:567-572
28. Arellanes-Garcia L, Bautista N, Mora P, et al. HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients. Ocul Immunol Inflamm 1998; 6:93-100
29. Goldberg AC, Yamamoto JH, Chiarella JM, et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998;59: 183-188
30. Weisz JM, Holland GN, Roer LN, et al. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. Ophthalmology 1995;102:1012-1015
31. Marsh SG. HLA class II region sequences, 1998. Tissue Antigens 1998;51:467-507
32. Shindo Y, Ohno S, Yamamoto T, et al. Complete association of the HLA-DRB1*04 and -DQB1*04 alleles with Vogt-Koyanagi-Harada's disease. Hum Immunol 1994;39:169-176
33. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994;78:223-226
34. Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 1996;80:1002-1008
35. Kobayashi H, Kokubo T, Takahashi M, et al. Tyrosinase epitope recognized by an HLA-DR-restricted T-cell line from a Vogt-Koyanagi-Harada disease patient. Immunogenetics 1998;47:398-403
36. Davis JL, Mittal KK, Freidlin V, et al. HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Ophthalmology 1990;97:1137-1142
37. Shindo Y, Ohno S, Usui M, et al. Immunogenetic study of sympathetic ophthalmia. Tissue Antigens 1997;49:111-115
38. Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens 1983;22:200-203
39. Martinetti M, Tinelli C, Kolek V, et al. "The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995;152:557-564
40. Nowack D, Goebel KM. Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study. Arch Intern Med 1987;147:481-483
41. Odum N, Milman N, Jakobsen BK, et al. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6. Exp Clin Immunogenet 1991; 8:227-232
42. Kunikane H, Abe S, Tsuneta Y, et al. Role of HLA-DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987;135:688-691
43. Pasturenzi L, Martinetti M, Cuccia M, et al. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. The Pavia-Padova Sarcoidosis Study Group. Chest 1993; 104:1170-1175
44. Abe S, Yamaguchi E, Makimura S, et al. Association of HLA-DR with sarcoidosis. Correlation with clinical course. Chest 1987;92:488-490
45. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system. Tissue Antigens 1992;39:161-173
46. Ishihara M, Ohno S, Ishida T, et al. Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 1994;43:238-241
47. Ishihara M, Ishida T, Mizuki N, et al. A case study of sibling relationship in sarcoidosis by HLA-DNA genotyping. Graefes Arch Clin Exp Ophthalmol 1994;232:761-762
48. Ishihara M, Ishida T, Mizuki N, et al. Clinical features of sarcoidosis in relation to HLA distribution and HLA-DRB3 genotyping by PCR-RFLP. Br J Ophthalmol 1995;79:322-325
49. Brown JH, Jardetzky T, Saper MA, et al. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature 1988;332:845-850
50. Ishihara M, Ohno S, Ishida T, et al. Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue Antigens 1995;46:59-62
51. Ishihara M, Ohno S. Genetic influences on sarcoidosis. Eye 1997;11:155-161
52. Ishihara M, Naruse T, Ohno S, et al. Analysis of HLA-DM polymorphisms in sarcoidosis. Hum Immunol 1996;49:144-146
53. Ishihara M, Ohno S, Ishida T, et al. Genetic polymorphism in intron 6 of the LMP7 gene in Japanese and its association with sarcoidosis. Tissue Antigens 1997;50:650-653
54. Ishihara M, Ohno S, Ishida T, et al. Analysis of allelic variation of the TAP2 gene in sarcoidosis. Tissue Antigens 1997;49:107-110
55. Wood P. Nomenculture and classification of arthritis in children. Basel: EULAR, 1978: 47-50
56. Brewer EJ Jr, Bass J, Baum J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum 1977;20: 195-199
57. Stastny P, Fink CW. Different HLA-D associations in adult and juvenile rheumatoid arthritis. J Clin Invest 1979;63:124-130
58. Forre O, Dobloug JH, Hoyeraal HM, Thorsby E. HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum 1983;26:35-38
59. Oen K, Petty RE, Schroeder ML. An association between HIA-A2 and juvenile rheumatoid arthritis in girls. J Rheumatol 1982;9:916-920
60. Van Kerckhove C, Melin-Aldana H, Elma MS, et al. A distinct HLA-DRw8 haplotype characterizes patients with juvenile rheumatoid arthritis. Immunogenetics 1990;32: 304-308
61. Haas JP, Nevinny-Stickel C, Schoenwald U, et al. Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol 1994;41:225-233
62. Melin-Aldana H, Giannini EH, Taylor J, et al. Human leukocyte antigen-DRB1*1104 in the chronic iridocyclitis of pauciarticular juvenile rheumatoid arthritis. J Pediatr 1992; 121:56-60
63. Ploski R, Vinje O, Ronningen KS, et al. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. DRB1*0101 may define a novel subset of the disease. Arthritis Rheum 1993;36:465-472
64. Okubo H, ltou K, Tanaka S, et al. Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. Rheumatol Int 1993;13:65-69
65. Ploski R, McDowell TL, Symons JA, et al. Interaction between HLA-DR and HLA-DP, and between HLA and interleukin 1 alpha in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease. Hum Immunol 1995;42:343-347
66. Mathon G, Pare C, Menard H, et al. [Juvenile rheumatoid arthritis and HLA-B27]. Can Med AssocJ 1980;123:377-379
67. Charmley P, Nepom BS, Concannon P. HLA and T cell receptor beta-chain DNA polymorphisms identify a distinct subset of patients with pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:695-701
68. Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103:137-145
69. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet 1973;2:994-996
70. Derhaag PJ, de Waal LP, Linssen A, Feltkamp TE. Acute anterior uveitis and HLA-B27 subtypes. Invest Ophthalmol Vis Sci 1988;29:1137-1140
71. Goto K, Ota M, Ando H, et al. MICA gene polymorphisms and HLA-B27 subtypes in Japanese patients with HLA-B27-associated acute anterior uveitis. Invest Ophthalmol Vis Sci 1998;39:634-637
72. van Bohemen CG, Grumet FC, Zanen HC. Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology 1984;52:607-610
73. Schwimmbeck PL, Yu DT, Oldstone MB. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166:173-181
74. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991;219:277-319
75. Maksymowych WP, Tao S, Li Y, et al. Allelic variation at the TAP 1 locus influences disease phenotype in HLA-B27 positive individuals with ankylosing spondylitis. Tissue Antigens 1995;45:328-332
76. Goto K, Ota M, Maksymowych WP, et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol 1998;126:436-441
77. Munteanu G. [Birdshot retinochoroidopathy]. Rev Chir Oncol Radiol ORL Oftalmol Stomatol Ser Oftalmol 1988;32:61-69
78. Nussenblatt RB, Mittal KK, Ryan S, et al. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol 1982;94:147-158
79. Baarsma GS, Priem HA, Kijlstra A. Association of birdshot retinochoroidopathy and HIA-A29 antigen. Curr Eye Res 1990;9:63-68
80. de Waal LP, Lardy NM, van der Horst AR, et al. HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics 1992;35:51-53
81. Boisgerault F, Khalil I, Tieng V, et al. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc Natl Acad Sci USA 1996;93:3466-3470
82. Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 1993;100:1199-1205
83. Tang WM, Pulido JS, Eckels DD, et al. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol 1997;123:70-75
84. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106:594-599
85. Kellar-Wood HF, Wood NW, Holmans P, et al. Multiple sclerosis and the HLA-D region: linkage and association studies. J Neuroimmunol 1995;58:183-190
86. Duquette P, Decary F, Pleines J, et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985;12:106-110